Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
192M
-
Number of holders
-
373
-
Total 13F shares, excl. options
-
157M
-
Shares change
-
+9.5M
-
Total reported value, excl. options
-
$19.5B
-
Value change
-
+$1.28B
-
Put/Call ratio
-
1.4
-
Number of buys
-
218
-
Number of sells
-
-143
-
Price
-
$124.62
Significant Holders of BIOMARIN PHARMACEUTICAL INC - COM (BMRN) as of Q1 2015
444 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - COM as of Q1 2015.
BIOMARIN PHARMACEUTICAL INC - COM (BMRN) has 373 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 157M shares
of 192M outstanding shares and own 81.64% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (19.5M shares), SANDS CAPITAL MANAGEMENT, LLC (12.3M shares), FMR LLC (11.9M shares), VANGUARD GROUP INC (10M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.17M shares), PRIMECAP MANAGEMENT CO/CA/ (8.03M shares), JENNISON ASSOCIATES LLC (5.4M shares), BAKER BROS. ADVISORS LP (4.2M shares), BlackRock Institutional Trust Company, N.A. (3.78M shares), and BlackRock Fund Advisors (3.38M shares).
This table shows the top 373 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.